DC Chemicals

All products / DC67106

BML-286 (Compound 3289-8625)
CAT. NO. DC67106

BML-286 (Compound 3289-8625)

Pack sizes and prices

Pack sizePrice
100mg$600 USDRequest a quote / confirm availability →
250mg$1,100 USDRequest a quote / confirm availability →
1g$2,200 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

BML-286 (Compound 3289-8625) is a small molecule inhibitor of the PDZ domain of dishevelled (Dvl) with KD of 10.6 uM, competitively inhibits the Wnt signaling. Compound 3289-8625 (3 uM) inhibits Wnt signaling, effectively reduces luciferase activity by about 2-fold 293 cell line stably transfected with a luciferase reporter. Compound 3289-8625 is cell-permeable and 3289-8625 (10 uM) blocks Wnt signaling in Xenopus, inhibits Wnt pathway responses in culture and in vivo. Compound 3289-8625 suppresses cell proliferation and reduces β-catenin level in prostate cancer PC-3 cells, decreases the levels of β-catenin in both cytosolic fraction and membrane fraction. Compound 3289-8625 sensitized A2780/Taxol cells to paclitaxel.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC67106
Product nameBML-286 (Compound 3289-8625)
CAS294891-81-9
Molecular formulaC22H18N2O4
Molecular weight374.38932
Purity>98%
SMILESO=C(Cc1ccccc1)Nc1cccc(C(=O)Nc2ccccc2C(=O)O)c1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — BML-286 (Compound 3289-8625) (DC67106)

Related research products

Browse newly added products